The Impact of MFN Pricing on the U.S. Biosimila...

By Rene Pretorius

May 23, 2025

Could a cost-cutting policy designed to rein in drug prices backfire on biosimilar competition? The Most Favored Nation
Biosimilars Price Competition: Impact on U.S. Pharmaceutical Pricing and Mark...
MFN Drug Pricing Targets: Lowering U.S. Drug Costs Through International Alig...
A System Dynamics Approach to Lowering Drug Prices by 30–80% in the US
FDA AI Drug Approval
Trump Science Publishing Critique: Analyzing Political Interference and Metho...
South Africa NHI Bill Court Ruling Calls for Scrutiny
Assessing Risks and Opportunities: The Impact of the CDC Hepatitis Lab Closure
Defunding Scientific Research: Implications and Misconceptions in GawandeR...
Advancing Early Childhood Health: PureHealth’s Partnership with Abu Dha...
South Africa Cannabis Regulations: Government Withdraws Ban for New Framework...
Trump Healthcare Policy Changes: Reversing Biden’s Executive Orders and...
Advancing EU Health Technology Assessment: Insights from the HAG Meeting